Offit et al., 1994 - Google Patents
Enhancement of rotavirus immunogenicity by microencapsulationOffit et al., 1994
- Document ID
- 7742627986341706007
- Author
- Offit P
- Khoury C
- Moser C
- Clark H
- Kim J
- Speaker T
- Publication year
- Publication venue
- Virology
External Links
Snippet
It was determined whether microencapsulation of rotavirus enhanced virus-specific Immunity in mice. Combinations of several water-soluble anionic polymers and amines were tested for their capacity to form microcapsules which were stable in the presence of simulated gastric …
- 241000702670 Rotavirus 0 title abstract description 73
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/245—Herpetoviridae, e.g. herpes simplex virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55555—Liposomes; Vesicles, e.g. nanoparticles; Spheres, e.g. nanospheres; Polymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
- A61K2039/541—Mucosal route
- A61K2039/542—Mucosal route oral/gastrointestinal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Offit et al. | Enhancement of rotavirus immunogenicity by microencapsulation | |
| US6531156B1 (en) | Aqueous solven encapsulation method, apparatus and microcapsules | |
| EP0804283B1 (en) | Aqueous solvent encapsulation method and microcapsules | |
| Herrmann et al. | Immune responses and protection obtained by oral immunization with rotavirus VP4 and VP7 DNA vaccines encapsulated in microparticles | |
| Eldridge et al. | Biodegradable microspheres: vaccine delivery system for oral immunization | |
| Eldridge et al. | Vaccine-containing biodegradable microspheres specifically enter the gut-associated lymphoid tissue following oral administration and induce a disseminated mucosal immune response | |
| US5417986A (en) | Vaccines against diseases caused by enteropathogenic organisms using antigens encapsulated within biodegradable-biocompatible microspheres | |
| Payne et al. | Water-soluble phosphazene polymers for parenteral and mucosal vaccine delivery | |
| US5569468A (en) | Vaccine delivery system for immunization, using biodegradable polymer microspheres | |
| US5529777A (en) | Hydrogel microencapsulated vaccines | |
| WO1985000014A1 (en) | Canine coronavirus vaccine | |
| US20020009466A1 (en) | Oral vaccine compositions | |
| CA2348285A1 (en) | Novel immunoadjuvants | |
| AU7328694A (en) | Hydrogel microencapsulated vaccines | |
| CA2341352A1 (en) | Oral vaccine compositions | |
| AU713639B2 (en) | Aqueous solvent based encapsulation of a bovine herpes virus type-1 subunit vaccine | |
| Muñoz et al. | Brucella outer membrane complex-loaded microparticles as a vaccine against Brucella ovis in rams | |
| US20180243228A1 (en) | Nanoparticle based vaccine strategy against swine influenza virus | |
| US10849962B2 (en) | Method and apparatus for microneedle transdermal delivery | |
| Bozkir et al. | Comparison of biodegradable nanoparticles and multiple emulsions (water-in-oil-in-water) containing influenza virus antigen on the in vivo immune response in rats | |
| US20100021546A1 (en) | Controlled-release immunogenic formulations to modulate immune response | |
| Patil et al. | Retention of trypsin activity in spermine alginate microcapsules | |
| US3962423A (en) | Live influenza type B virus vaccines and preparation thereof | |
| Kidane et al. | The efficacy of oral vaccination of mice with alginate encapsulated outer membrane proteins of Pasteurella haemolytica and One-Shot® | |
| Moser et al. | Effect of microencapsulation on immunogenicity of a bovine herpes virus glycoprotein and inactivated influenza virus in mice |